Trademark: 98739871
Word
BESREMI MPEN
Status
Pending
Status Code
630
Status Date
Monday, September 9, 2024
Serial Number
98739871
Mark Type
4
Filing Date
Monday, September 9, 2024
Trademark Owner History
PHARMAESSENTIA CORPORATION
Classifications
5 Pharmaceutical preparations contained in pen injectors; Pharmaceutical preparations, namely, ropeginterferon alfa-2b, contained in injectors for treatment of viral infections, cancers, polycythemia vera, essential thrombocythemia, myelofibrosis, and/or other myeloproliferative neoplasms; Pharmaceutical preparations contained in injectors for treatment of myeloproliferative neoplasms; Pharmaceutical preparations contained in pen injectors for treatment of myeloproliferative neoplasms; Pharmaceutical preparations, namely, ropeginterferon alfa-2b, contained in pen injectors for treatment of viral infections, cancers, polycythemia vera, essential thrombocythemia, myelofibrosis, and/or other myeloproliferative neoplasms; Pharmaceutical preparations contained in injectors
Trademark Events
Sep 9, 2024
New Application Entered
Sep 9, 2024
New Application Office Supplied Data Entered
Sep 9, 2024
Application Filing Receipt Mailed
DAIWA
D
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - Twit Solutions PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov